HIGHLIGHTS
- who: Cong Wei from the Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China have published the paper: Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients, in the Journal: (JOURNAL)
- what: The analysis demonstrated that MCPMI-high patients were more sensitive to cytarabine, bortezomib, lestaurtinib, BI 2536, and ponatinib than MCPMI-low patients, and these drugs may provide better treatment options for MCPMI-high patients.
- how: The authors applied LASSO Cox proportional hazards regression modeling (glmnet R software) to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.